By Counterforce Health Team in Qalsody (tofersen) —

Work With Your Doctor to Get Qalsody (Tofersen) Approved by Cigna in North Carolina: Complete Provider Partnership Guide

Answer Box: Getting Qalsody (Tofersen) Approved by Cigna in North Carolina

Eligibility: Adults with ALS due to confirmed SOD1 mutation, prescribed by a neurologist, with documented step therapy (riluzole/edaravone trials).

Fastest Path: Partner with your ALS specialist to submit prior authorization through Cigna's provider portal with complete SOD1 genetic testing, ALSFRS-R scores, and medical necessity letter citing updated CMS guidance.

Start Today: Contact your neurologist's office to schedule a visit focused on Qalsody approval preparation and request copies of all ALS-related medical records.

Table of Contents

  1. Set Your Goal: Understanding Qalsody Approval Requirements
  2. Prepare for Your Provider Visit
  3. Build Your Evidence Kit
  4. Partner on the Medical Necessity Letter
  5. Support Peer-to-Peer Review
  6. Document Everything After Your Visit
  7. Practice Respectful Persistence
  8. Appeals Process in North Carolina
  9. Common Denial Reasons & Solutions
  10. FAQ

Set Your Goal: Understanding Qalsody Approval Requirements

Qalsody (tofersen) requires strict prior authorization from Cigna, typically processed through Express Scripts or Accredo specialty pharmacy. Success depends on a strong partnership between you and your neurologist to meet specific clinical criteria.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
SOD1 Mutation Lab-confirmed pathogenic SOD1 variant Certified genetics lab report
Neurologist Prescriber ALS specialist or board-certified neurologist Provider credentials verification
Step Therapy Prior riluzole/edaravone trials documented Medical records, pharmacy claims
ALSFRS-R Score Baseline functional assessment ≥24 Clinical documentation
Prior Authorization Mandatory submission before coverage Cigna PA portal
Note: As of December 2024, CMS directed Medicare Advantage plans to cover Qalsody for on-label SOD1-ALS, making "experimental" denials invalid for appeals.

Your neurologist will be your primary advocate throughout this process. At roughly $200,000+ annually, Qalsody requires comprehensive documentation that only your specialist can provide.

Prepare for Your Provider Visit

Come to your appointment prepared to help your doctor build the strongest possible case for approval.

Symptom Timeline Documentation

Create a detailed timeline including:

  • First symptoms noticed (weakness, muscle twitching, speech changes)
  • Progression pattern (which body areas affected first, how symptoms spread)
  • Functional impacts (difficulty walking, swallowing, breathing)
  • Current limitations compared to 6-12 months ago

Treatment History Summary

Document all ALS medications tried:

  • Riluzole: dates used, dosing, effectiveness, side effects, reason for stopping
  • Edaravone (Radicava): infusion history, tolerability, clinical response
  • Other therapies: supplements, off-label medications, clinical trials

Current Functional Status

Prepare to discuss:

  • Activities of daily living you can/cannot perform independently
  • Need for assistive devices (walker, wheelchair, feeding tube)
  • Respiratory function and ventilation status
  • Speech and swallowing abilities
Tip: Bring a family member who can provide additional perspective on your functional decline and treatment responses.

Build Your Evidence Kit

Work with your clinic to gather essential documentation before the prior authorization submission.

Required Laboratory Evidence

SOD1 Genetic Testing Results

  • Complete lab report from CLIA-certified laboratory
  • Specific mutation identified (e.g., p.Ala5Val, p.Ala5Thr)
  • Test date and methodology
  • Laboratory contact information

Baseline Assessments

  • ALSFRS-R score documentation (≥24 required)
  • Neurofilament light chain (NfL) levels if available
  • Pulmonary function tests
  • Recent EMG/nerve conduction studies

Clinical Documentation Package

Your neurologist will need:

  • Complete ALS diagnostic workup and El Escorial criteria fulfillment
  • Serial ALSFRS-R scores showing progression
  • Clinic visit notes documenting functional decline
  • Pharmacy records or insurance claims for prior ALS therapies

Published Guidelines Support

Help your provider access:

Partner on the Medical Necessity Letter

The medical necessity letter is crucial for approval. Work with your neurologist to ensure it addresses all key elements.

Essential Letter Components

Patient Identification & Diagnosis

  • Full name, date of birth, insurance information
  • ALS diagnosis with ICD-10 code (G12.21)
  • Date of diagnosis and diagnostic criteria met

Genetic Documentation

  • SOD1 mutation type and pathogenicity classification
  • Laboratory that performed testing
  • Clinical significance of the specific variant

Clinical Rationale

  • Current functional status and rate of progression
  • Why Qalsody is medically necessary for this patient
  • Risks of delaying treatment
  • Expected clinical benefits

Step Therapy Documentation

  • Previous ALS therapies tried with dates
  • Reasons for discontinuation (ineffective, intolerant, contraindicated)
  • Current medications and dosing

Regulatory Support

  • Reference to FDA approval for SOD1-ALS
  • Citation of updated CMS coverage policy
  • Relevant clinical guidelines supporting use
From Our Advocates: We've seen approvals accelerated when neurologists include specific quotes from the FDA label and explicitly reference the December 2024 CMS guidance preventing "experimental" denials. This regulatory backing strengthens the medical necessity argument significantly.

Support Peer-to-Peer Review

If initial prior authorization is denied, your neurologist may request a peer-to-peer review with a Cigna medical director.

How to Help Your Provider

Provide Availability Windows

  • Offer to be available during the call if permitted
  • Provide flexible scheduling options for your neurologist
  • Ensure all documentation is readily accessible

Prepare Concise Case Summary Help your provider prepare a 2-3 minute overview including:

  • Your age, SOD1 mutation type, and ALS progression timeline
  • Previous therapies tried and outcomes
  • Current functional limitations and prognosis
  • Why Qalsody is the appropriate next step

Key Discussion Points

Your neurologist should emphasize:

  • Qalsody is the only FDA-approved therapy targeting SOD1-ALS
  • Time-sensitive nature of ALS progression
  • Patient meets all clinical criteria in Cigna's policy
  • Regulatory support preventing experimental designation

Document Everything After Your Visit

Maintain organized records to support ongoing approval efforts and potential appeals.

What to Save

Provider Communications

  • Copies of all prior authorization submissions
  • Confirmation numbers and submission dates
  • Provider portal screenshots or email confirmations

Clinical Documentation

  • Updated clinic visit summaries
  • New test results or assessments
  • Medication trial documentation

Insurance Correspondence

  • Denial letters with specific reasons cited
  • Appeal deadlines and reference numbers
  • Customer service call logs with dates and representatives

Portal Communication Tips

When messaging your provider through patient portals:

  • Use clear subject lines: "Qalsody PA Update Needed"
  • Include relevant dates and reference numbers
  • Ask specific questions rather than general requests
  • Attach any new documentation you've received

Practice Respectful Persistence

Maintain regular communication while respecting your provider's time and processes.

Appropriate Follow-Up Cadence

Week 1-2: Allow time for initial submission processing Week 3: Check on submission status if no response Week 4+: Weekly updates appropriate if still pending

How to Escalate Politely

If facing delays:

  1. Request status update through normal clinic channels first
  2. Ask about expedited review if clinically appropriate
  3. Inquire about alternative approaches (different PA pathways, appeal preparation)
  4. Request supervisor involvement only after other options exhausted

When to Seek Additional Support

Consider contacting Counterforce Health if you're experiencing:

  • Repeated denials despite meeting criteria
  • Difficulty coordinating between your provider and Cigna
  • Complex appeal requirements beyond your clinic's capacity

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to draft targeted, evidence-backed rebuttals aligned with payer requirements.

Appeals Process in North Carolina

North Carolina offers strong consumer protections through Smart NC and robust external review rights.

Cigna Internal Appeals

Timeline: 180 days from denial date Process: Submit through Cigna member portal or by mail Documentation: Include all clinical records, genetic testing, and updated medical necessity letter

North Carolina External Review

If Cigna upholds the denial, you can request external review through Smart NC:

Contact: 1-855-408-1212 Timeline: 120 days after final internal denial Process: Independent Review Organization (IRO) makes binding decision Standard Review: 45 days for decision Expedited Review: 72 hours for urgent cases

Note: Smart NC provides free advocacy and can help gather supporting documentation for your external review.

Step-by-Step Appeals Process

  1. File Internal Appeal with Cigna within 180 days
  2. Request Expedited Review if rapid ALS progression documented
  3. Submit External Review to Smart NC if internal appeal denied
  4. Provide Additional Documentation within 7 days of external review acceptance

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
No SOD1 mutation documented Submit certified genetic testing report CLIA lab results with specific variant
Insufficient step therapy Provide detailed treatment history Pharmacy records, clinic notes
Non-neurologist prescriber Transfer care or obtain consultation Board certification verification
"Experimental" designation Reference CMS guidance and FDA approval Updated regulatory documents
Incomplete clinical documentation Submit comprehensive medical necessity letter ALSFRS-R scores, progression notes

FAQ

How long does Cigna prior authorization take in North Carolina? Standard review takes 15 business days. Expedited review (for urgent cases) takes 72 hours. Your neurologist can request expedited review if delay would harm your health.

What if Qalsody is not on Cigna's formulary? Request a formulary exception through your provider. Include medical necessity documentation and reference that Qalsody is the only FDA-approved SOD1-targeted therapy.

Can I appeal if I tried riluzole outside North Carolina? Yes. Step therapy requirements apply regardless of where previous treatments were tried. Include all medical records and pharmacy documentation.

Does Cigna cover genetic testing for SOD1? Most Cigna plans cover ALS genetic testing when ordered by a neurologist. Check your specific plan's genetic testing policy.

What if my neurologist isn't familiar with Qalsody approval? Share this guide with your provider and suggest they contact Biogen's medical affairs team for clinical support and approval guidance.

How much will Qalsody cost with Cigna coverage? Costs depend on your specific plan's specialty tier copayment or coinsurance. Contact Cigna member services for your exact out-of-pocket costs.

Can Smart NC help with my appeal? Yes. Smart NC provides free advocacy for North Carolina residents with state-regulated insurance plans. They can help prepare your external review application and gather supporting documentation.

What happens if external review is denied? External review decisions are binding on Cigna. If denied, you've exhausted administrative appeals, though other legal options may exist depending on your specific circumstances.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Coverage policies and requirements may change. For additional support with complex insurance appeals, consider consulting with organizations like Counterforce Health that specialize in prescription drug access advocacy.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.